DK0939613T3 - Mundskyllemiddel, der omfatter calcium- og phosphationer i en overmættet opløsning - Google Patents

Mundskyllemiddel, der omfatter calcium- og phosphationer i en overmættet opløsning

Info

Publication number
DK0939613T3
DK0939613T3 DK97941536T DK97941536T DK0939613T3 DK 0939613 T3 DK0939613 T3 DK 0939613T3 DK 97941536 T DK97941536 T DK 97941536T DK 97941536 T DK97941536 T DK 97941536T DK 0939613 T3 DK0939613 T3 DK 0939613T3
Authority
DK
Denmark
Prior art keywords
calcium
supersaturated solution
phosphate ions
oral rinse
supersaturated
Prior art date
Application number
DK97941536T
Other languages
Danish (da)
English (en)
Inventor
Erling Johansen
Thor Olsen
Athena Papas
Original Assignee
Erling Johansen
Thor Olsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9619464.2A external-priority patent/GB9619464D0/en
Application filed by Erling Johansen, Thor Olsen filed Critical Erling Johansen
Application granted granted Critical
Publication of DK0939613T3 publication Critical patent/DK0939613T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Biotechnology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97941536T 1996-09-18 1997-09-18 Mundskyllemiddel, der omfatter calcium- og phosphationer i en overmættet opløsning DK0939613T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2657896P 1996-09-18 1996-09-18
GBGB9619464.2A GB9619464D0 (en) 1996-09-18 1996-09-18 Compositions
PCT/US1997/016125 WO1998011866A1 (en) 1996-09-18 1997-09-18 Mouthwash comprising calcium and phosphate ions in supersaturated solution

Publications (1)

Publication Number Publication Date
DK0939613T3 true DK0939613T3 (da) 2003-07-14

Family

ID=26310059

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97941536T DK0939613T3 (da) 1996-09-18 1997-09-18 Mundskyllemiddel, der omfatter calcium- og phosphationer i en overmættet opløsning

Country Status (13)

Country Link
US (3) US5993785A (pt)
EP (1) EP0939613B1 (pt)
JP (2) JP3895388B2 (pt)
AT (1) ATE238761T1 (pt)
AU (1) AU4342497A (pt)
CA (1) CA2266409C (pt)
DE (1) DE69721556T2 (pt)
DK (1) DK0939613T3 (pt)
ES (1) ES2197364T3 (pt)
GB (1) GB2318977B (pt)
NO (1) NO313367B1 (pt)
PT (1) PT939613E (pt)
WO (1) WO1998011866A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI980051A1 (it) * 1998-03-06 1999-09-06 Italmed Di Galli Giovanna E Pa Composizione ad uso odontoiatrico per la desensibilizzazione della dentina esposta
NL1018208C2 (nl) * 2001-06-05 2002-12-10 Calcio B V Tandpasta.
TWI231182B (en) * 2001-12-11 2005-04-21 Shinkatsu Morisawa The effect of a buffering agent on acidogenesis of plaque
EP1607005B1 (en) * 2001-12-11 2008-10-08 Xiao Bing Wang The effect of a buffering agent on acidogenesis of plaque
CN1298309C (zh) * 2001-12-11 2007-02-07 王小兵 缓冲剂对牙菌斑酸化的作用
US6610275B1 (en) * 2002-02-13 2003-08-26 Joseph L. Owades Device for treating drinking water to make it hostile to dental plaque
US9011823B2 (en) 2005-02-01 2015-04-21 Ada Foundation Enhanced anti-carious dentifrices, rinses, lozenges, candies and chewing gums and methods of using same
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
CA2689658A1 (en) * 2007-06-20 2008-12-24 Actogenix Nv Methods and compositions for treating mucositis
WO2009146104A1 (en) 2008-04-02 2009-12-03 Accentia Biopharmaceuticals, Inc. Formulations, devices and methods for treating and preventing mucositis
US20110086108A1 (en) * 2009-10-12 2011-04-14 Bartholomew Weldon Dissolving powders that can be mixed with water and used as an oral rinse
WO2011109919A1 (en) 2010-03-09 2011-09-15 Unilever Plc Stable oral care compositions
WO2012135426A2 (en) * 2011-03-29 2012-10-04 New York University Anti-bacterial and mineralizing calcium phosphate compositions
WO2012156502A2 (en) * 2011-05-18 2012-11-22 Arcoral Pharma As Two component mouth rinse preparation
JP6175428B2 (ja) 2011-06-01 2017-08-02 イントレクソン・アクトバイオテイクス・エヌブイＩｎｔｒｅｘｏｎ Ａｃｔｏｂｉｏｔｉｃｓ ＮＶ 細菌のポリシストロン性発現系
CA2891362C (en) 2012-11-16 2020-04-21 Arcoral Pharma As Effervescent tablet
WO2015013549A1 (en) 2013-07-25 2015-01-29 Invado Pharmaceuticals, LLC Treating oral inflammation, injury or pain
JP5764712B1 (ja) * 2014-12-16 2015-08-19 株式会社松風 歯質再生剤
US11590165B2 (en) * 2014-12-17 2023-02-28 Bausch Health Companies Inc. Formulations of calcium and phosphate for oral inflammation
US20180353416A1 (en) * 2015-10-26 2018-12-13 Colgate-Palmolive Company Oral care products and methods
BR112018010091A2 (pt) 2015-11-19 2019-02-05 Fantarella & Harewood LLC colutório não alcoólico e método para inibir o crescimento de células de bactérias na boca
DK3402499T3 (da) 2016-01-14 2021-09-27 Intrexon Actobiotics Nv Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes
US20190110971A1 (en) * 2016-04-28 2019-04-18 The Regents Of The University Of California Compositions for managing plaque formation
WO2018042390A1 (en) 2016-09-02 2018-03-08 Intrexon Actobiotics N.V. Genetically modified bacteria stably expressing il-10 and insulin
IL265177B1 (en) 2016-09-13 2024-09-01 Intrexon Actobiotics N V A microorganism that adheres to the mucosa
DK3615041T3 (da) * 2017-04-25 2022-04-04 Nutreco Ip Assets Bv Calciumbindemiddel til brug for at forhindre dødfødsel
US11642199B2 (en) * 2018-09-24 2023-05-09 3M Innovative Properties Company Dental appliance with cosmetic therapeutic aqueous solution
US20220340621A1 (en) 2019-09-27 2022-10-27 Intrexon Actobiotics Nv D/B/A Precigen Actobio Treatment of celiac disease
US11903992B2 (en) * 2021-01-23 2024-02-20 Cellix Bio Private Limited Composition comprising lidocaine, l-carnosine and dexpanthenol

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492247A1 (de) * 1964-03-20 1969-11-06 Warner Lambert Pharmaceutical Verfahren zum Wiederverhaerten von Zahnschmelz und dafuer geeignetes Zahnpflegemittel
US3679360A (en) * 1970-06-26 1972-07-25 Nasa Process for the preparation of brushite crystals
GB1408922A (en) * 1972-02-02 1975-10-08 Blendax Werke Schneider Co Process and composition for the remineralisation and prevention of demineralisation of human teeth
US4048300A (en) * 1973-01-11 1977-09-13 Colgate-Palmolive Company Dental preparation containing materials having calcium and phosphate components
US4108980A (en) * 1973-01-11 1978-08-22 Colgate-Palmolive Company Process of preparing materials having calcium and phosphate components
DE2452969A1 (de) * 1973-11-13 1975-05-15 Procter & Gamble Mittel zum remineralisieren von zahnschmelz
US4080440A (en) * 1974-12-13 1978-03-21 The Procter & Gamble Company Method for remineralizing tooth enamel
US4097588A (en) * 1975-03-11 1978-06-27 National Research Development Corporation Mineralizing dental mouthrinse
US4083955A (en) * 1975-04-02 1978-04-11 The Procter & Gamble Company Processes and compositions for remineralization of dental enamel
GB1509977A (en) * 1975-10-31 1978-05-10 Nat Res Dev Remineralising composition
US4097935A (en) * 1976-07-21 1978-07-04 Sterling Drug Inc. Hydroxylapatite ceramic
US4183915A (en) * 1978-10-13 1980-01-15 Colgate-Palmolive Company Stable solution for dental remineralization
US4177258A (en) * 1978-10-13 1979-12-04 Colgate Palmolive Company Dentifrice for dental remineralization
US4348381A (en) * 1981-05-06 1982-09-07 Colgate-Palmolive Company Dental remineralization composition
US4606912A (en) * 1981-07-22 1986-08-19 Caries Research Group Of Rochester, Inc. Method of making a clear, stable aqueous mouthwash solution and the solution made by that method for the enhancement of cells of the oral cavity and the remineralization of teeth
US4532124A (en) * 1981-08-19 1985-07-30 Development Finance Corporation Of New Zealand Dental rinse
US5460803A (en) * 1989-05-24 1995-10-24 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5037639A (en) * 1989-05-24 1991-08-06 American Dental Association Health Foundation Methods and compositions for mineralizing calcified tissues
US5427768A (en) * 1993-06-23 1995-06-27 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
US5658554A (en) 1995-06-01 1997-08-19 Colgate-Palmolive Company Mouth moistener for the relief of dry mouth condition
US5605675A (en) * 1995-06-06 1997-02-25 Enamelon Inc. Processes and compositions for remineralization and prevention of demineralization of dental enamel
US5571502A (en) * 1995-08-08 1996-11-05 Enamelon Research Stable single-part compositions and the use thereof for remineralization of lesions in teeth
US5603922A (en) * 1995-08-08 1997-02-18 Enamelon Inc. Processes and compositions for the remineralization of teeth

Also Published As

Publication number Publication date
AU4342497A (en) 1998-04-14
CA2266409C (en) 2009-01-06
NO991302D0 (no) 1999-03-17
US5993785A (en) 1999-11-30
PT939613E (pt) 2003-07-31
JP2001500874A (ja) 2001-01-23
US20020044910A1 (en) 2002-04-18
EP0939613B1 (en) 2003-05-02
DE69721556D1 (de) 2003-06-05
US20030152530A1 (en) 2003-08-14
JP4746441B2 (ja) 2011-08-10
WO1998011866A1 (en) 1998-03-26
NO313367B1 (no) 2002-09-23
GB2318977B (en) 1999-07-21
CA2266409A1 (en) 1998-03-26
ATE238761T1 (de) 2003-05-15
NO991302L (no) 1999-03-17
JP3895388B2 (ja) 2007-03-22
GB9719780D0 (en) 1997-11-19
EP0939613A1 (en) 1999-09-08
US6387352B1 (en) 2002-05-14
DE69721556T2 (de) 2004-03-04
ES2197364T3 (es) 2004-01-01
JP2006199702A (ja) 2006-08-03
GB2318977A (en) 1998-05-13

Similar Documents

Publication Publication Date Title
DK0939613T3 (da) Mundskyllemiddel, der omfatter calcium- og phosphationer i en overmættet opløsning
SE8201086L (sv) Dental remineraliseringskomposition
DE69224908D1 (de) Dentale schale
SE7905790L (sv) Stabil komposition for dental remineralisering
NO970051L (no) Vandige risperidon formuleringer
FI952110A0 (fi) Remineralisoiva hammashoitoaine
ZA88798B (en) Dental anti-plaque and anti-caries agent
DE69739440D1 (de) Orale anti-karies zusammensetzung
HUP0301164A2 (hu) Eljárás biszfoszfonátok adagolására
DE60022180D1 (de) Dentales produkt gegen zahnstein und betreffende methode
WO2001041753A3 (en) Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds
EP0875238A3 (en) Dentifrice compositions containing Beta-phase calcium pyrophosphate, an anticalculus agent & fluoride
BR9904613A (pt) Utilização de uma goma de silicone, composição tópica e utilização de uma composição
BRPI0413566A (pt) composição de branqueamento de dentes, e, métodos de branqueamento de uma superfìcie de um dente em um cavidade oral de um paciente e de branqueamento de um dente em um mamìfero
DE69926859D1 (de) Gebissreinigungsmittel
IS1791B (is) Yfirborðsmeðhöndlun á tannrótaryfirborði
ATE238750T1 (de) Kit zur konditionierung von zahnkavitäten
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
MD1473G2 (ro) Remediu antiherpetic
ES2087863T3 (es) Composicion limpiacristales.
SE8703512D0 (sv) Medel for tandbehandling
GR77250B (pt)
DE69808663D1 (de) Neomycin/disaccharid wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie
UA20075A (uk) Спосіб діагhостуваhhя та лікуваhhя стійких фуhкціоhальhих зміщеhь hижhьої щелепи
UA32146A (uk) Спосіб оцінки ефективності лікування пародонтита